Kimia Biosciences Limited (BOM:530313)

Kimia Biosciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	1,259	1,189	1,049	1,285	1,249	1,327
Revenue	1,259	1,189	1,049	1,285	1,249	1,327
Revenue Growth (YoY)	13.47%	13.39%	-18.39%	2.89%	-5.89%	24.86%
Cost of Revenue	788.66	722.18	765.16	977.05	934.67	979.44
Gross Profit	470.62	467.03	283.6	308.11	314.34	347.7
Selling, General & Admin	136.7	149.86	167.71	181.01	158.49	154.72
Other Operating Expenses	136.1	114.68	112.6	156.53	149.35	109.2
Operating Expenses	309.17	298.32	313.23	370.86	337.25	283.02
Operating Income	161.45	168.71	-29.63	-62.75	-22.91	64.68
Interest Expense	-31.4	-35.33	-44.46	-37.41	-31.01	-24.79
Interest & Investment Income	0.22	0.22	0.37	0.29	0.31	0.54
Currency Exchange Gain (Loss)	5.89	5.89	-0.75	-14.54	2.41	13.09
Other Non Operating Income (Expenses)	-5.78	-3.15	-0.99	0.25	0.21	1.02
EBT Excluding Unusual Items	130.38	136.34	-75.46	-114.16	-50.99	54.55
Gain (Loss) on Sale of Investments	-	-	0	0.03	0.02	0.41
Gain (Loss) on Sale of Assets	-	-	-	-	0.79	0.37
Other Unusual Items	-	-	3.62	-9.75	-	0.02
Pretax Income	130.38	136.34	-71.84	-123.88	-50.18	55.34
Income Tax Expense	39.85	40.22	-18.75	-30.36	-13.15	4.3
Net Income	90.52	96.12	-53.09	-93.52	-37.03	51.04
Net Income to Common	90.52	96.12	-53.09	-93.52	-37.03	51.04
Net Income Growth	-3.86%	-	-	-	-	269.56%
Shares Outstanding (Basic)	47	47	47	47	47	47
Shares Outstanding (Diluted)	47	47	47	47	47	47
Shares Change (YoY)	0.13%	-	-	-	-	-
EPS (Basic)	1.91	2.03	-1.12	-1.98	-0.78	1.08
EPS (Diluted)	1.91	2.03	-1.12	-1.98	-0.78	1.08
EPS Growth	-4.07%	-	-	-	-	280.93%
Free Cash Flow	-	167.15	130.28	-95.82	44.17	-75.94
Free Cash Flow Per Share	-	3.53	2.75	-2.02	0.93	-1.60
Gross Margin	37.37%	39.27%	27.04%	23.97%	25.17%	26.20%
Operating Margin	12.82%	14.19%	-2.83%	-4.88%	-1.83%	4.87%
Profit Margin	7.19%	8.08%	-5.06%	-7.28%	-2.96%	3.85%
Free Cash Flow Margin	-	14.06%	12.42%	-7.46%	3.54%	-5.72%
EBITDA	193.44	200.85	2.72	-30.03	6.05	83.29
EBITDA Margin	15.36%	16.89%	0.26%	-2.34%	0.48%	6.28%
D&A For EBITDA	31.99	32.14	32.35	32.73	28.96	18.61
EBIT	161.45	168.71	-29.63	-62.75	-22.91	64.68
EBIT Margin	12.82%	14.19%	-2.83%	-4.88%	-1.83%	4.87%
Effective Tax Rate	30.57%	29.50%	-	-	-	7.77%
Revenue as Reported	1,270	1,202	1,065	1,297	1,258	1,352
Advertising Expenses	-	9.62	12.43	14.13	5.29	11.53

Source: S&P Global Market Intelligence. Standard template. Financial Sources.